Literature DB >> 33771992

Nonlinear machine learning pattern recognition and bacteria-metabolite multilayer network analysis of perturbed gastric microbiome.

Claudio Durán1, Sara Ciucci1, Alessandra Palladini1,2,3, Umer Z Ijaz4, Antonio G Zippo5, Francesco Paroni Sterbini6, Luca Masucci6, Giovanni Cammarota7, Gianluca Ianiro7, Pirjo Spuul8, Michael Schroeder9, Stephan W Grill9,10, Bryony N Parsons11, D Mark Pritchard11,12, Brunella Posteraro6, Maurizio Sanguinetti6, Giovanni Gasbarrini7, Antonio Gasbarrini7, Carlo Vittorio Cannistraci13,14.   

Abstract

The stomach is inhabited by diverse microbial communities, co-existing in a dynamic balance. Long-term use of drugs such as proton pump inhibitors (PPIs), or bacterial infection such as Helicobacter pylori, cause significant microbial alterations. Yet, studies revealing how the commensal bacteria re-organize, due to these perturbations of the gastric environment, are in early phase and rely principally on linear techniques for multivariate analysis. Here we disclose the importance of complementing linear dimensionality reduction techniques with nonlinear ones to unveil hidden patterns that remain unseen by linear embedding. Then, we prove the advantages to complete multivariate pattern analysis with differential network analysis, to reveal mechanisms of bacterial network re-organizations which emerge from perturbations induced by a medical treatment (PPIs) or an infectious state (H. pylori). Finally, we show how to build bacteria-metabolite multilayer networks that can deepen our understanding of the metabolite pathways significantly associated to the perturbed microbial communities.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33771992     DOI: 10.1038/s41467-021-22135-x

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  87 in total

1.  Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report.

Authors:  Peter Malfertheiner; Francis Megraud; Colm A O'Morain; John Atherton; Anthony T R Axon; Franco Bazzoli; Gian Franco Gensini; Javier P Gisbert; David Y Graham; Theodore Rokkas; Emad M El-Omar; Ernst J Kuipers
Journal:  Gut       Date:  2012-05       Impact factor: 23.059

2.  16S community profiling identifies proton pump inhibitor related differences in gastric, lung, and oropharyngeal microflora.

Authors:  Rachel Rosen; Lan Hu; Janine Amirault; Umakanth Khatwa; Doyle V Ward; Andrew Onderdonk
Journal:  J Pediatr       Date:  2015-02-04       Impact factor: 4.406

Review 3.  The effect of proton pump inhibitors on the human microbiota.

Authors:  B J Vesper; A Jawdi; K W Altman; G K Haines; L Tao; J A Radosevich
Journal:  Curr Drug Metab       Date:  2009-01       Impact factor: 3.731

Review 4.  Microbiota in the stomach: new insights.

Authors:  Wen Ming Wu; Yun Sheng Yang; Li Hua Peng
Journal:  J Dig Dis       Date:  2014-02       Impact factor: 2.325

Review 5.  The impact of proton pump inhibitors on the human gastrointestinal microbiome.

Authors:  Daniel E Freedberg; Benjamin Lebwohl; Julian A Abrams
Journal:  Clin Lab Med       Date:  2014-09-24       Impact factor: 1.935

6.  We Are Using Too Many PPIs, and We Need to Stop: A European Perspective.

Authors:  Angel Lanas
Journal:  Am J Gastroenterol       Date:  2016-05-10       Impact factor: 10.864

Review 7.  Gut microbiome as a clinical tool in gastrointestinal disease management: are we there yet?

Authors:  Eamonn M M Quigley
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-03-30       Impact factor: 46.802

Review 8.  25 Years of Proton Pump Inhibitors: A Comprehensive Review.

Authors:  Daniel S Strand; Daejin Kim; David A Peura
Journal:  Gut Liver       Date:  2017-01-15       Impact factor: 4.519

9.  When is proton pump inhibitor use appropriate?

Authors:  Rena Yadlapati; Peter J Kahrilas
Journal:  BMC Med       Date:  2017-02-21       Impact factor: 8.775

Review 10.  Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppression.

Authors:  Carmelo Scarpignato; Luigi Gatta; Angelo Zullo; Corrado Blandizzi
Journal:  BMC Med       Date:  2016-11-09       Impact factor: 8.775

View more
  5 in total

Review 1.  Microbial metabolites in the marine carbon cycle.

Authors:  Mary Ann Moran; Elizabeth B Kujawinski; William F Schroer; Shady A Amin; Nicholas R Bates; Erin M Bertrand; Rogier Braakman; C Titus Brown; Markus W Covert; Scott C Doney; Sonya T Dyhrman; Arthur S Edison; A Murat Eren; Naomi M Levine; Liang Li; Avena C Ross; Mak A Saito; Alyson E Santoro; Daniel Segrè; Ashley Shade; Matthew B Sullivan; Assaf Vardi
Journal:  Nat Microbiol       Date:  2022-04-01       Impact factor: 30.964

2.  Age-sex population adjusted analysis of disease severity in epidemics as a tool to devise public health policies for COVID-19.

Authors:  Carlo Vittorio Cannistraci; Maria Grazia Valsecchi; Ilaria Capua
Journal:  Sci Rep       Date:  2021-06-03       Impact factor: 4.379

3.  Lactobacillus acidophilus DDS-1 Modulates the Gut Microbial Co-Occurrence Networks in Aging Mice.

Authors:  Ravichandra Vemuri; Christopher J Martoni; Kylie Kavanagh; Rajaraman Eri
Journal:  Nutrients       Date:  2022-02-25       Impact factor: 5.717

4.  Identifying cellular cancer mechanisms through pathway-driven data integration.

Authors:  Sam F L Windels; Noël Malod-Dognin; Nataša Pržulj
Journal:  Bioinformatics       Date:  2022-08-02       Impact factor: 6.931

5.  Progress in elucidating the relationship between Helicobacter pylori infection and intestinal diseases.

Authors:  Shunji Fujimori
Journal:  World J Gastroenterol       Date:  2021-12-21       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.